{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:06:07Z","timestamp":1779771967944,"version":"3.53.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease characterized by sustained inflammation and fibrosis, for which effective disease-modifying therapies remain limited. In this study, we investigated the hepatoprotective effects of Hongjam, a processed edible silkworm-derived food, in a methionine-choline-deficient (MCD) diet-induced mouse model of MASH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Histological analysis, plasma biochemical assessments, western blotting, quantitative PCR analyses, and in vitro experiments using macrophages and HepG2 hepatocyte-derived cells were performed to evaluate the effects of Hongjam and silk fibroin peptides associated with Hongjam.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Hongjam markedly alleviated hepatic injury, as evidenced by improved histological features, normalization of plasma biochemical parameters, and reduced collagen deposition. Mechanistically, Hongjam suppressed activation of the TGF-\u03b2\/Smad signaling pathway, inhibited NF-\u03baB-mediated inflammatory signaling, and attenuated MCD-associated metabolic stress signaling, including changes in AMPK phosphorylation and the expression of genes involved in fatty acid oxidation and lipid transport. Consistent with the in vivo findings, silk fibroin peptides associated with Hongjam attenuated NF-\u03baB-mediated inflammatory signaling in macrophages and modulated TGF-\u03b2\/Smad-associated signaling in HepG2 hepatocyte-derived cells in vitro<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Collectively, these results demonstrate that Hongjam attenuates experimental MASH by concurrently modulating metabolic stress, inflammation, and fibrotic remodeling. These findings highlight Hongjam as a food-derived candidate with potential relevance for dietary strategies targeting metabolic liver diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1839551","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:50:09Z","timestamp":1779771009000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Hongjam, an edible silkworm-derived food, attenuates steatohepatitis and fibrosis via multi-axis modulation of metabolic stress, inflammation, and fibrogenic signaling"],"prefix":"10.3389","volume":"13","author":[{"given":"Hye-Rin","family":"Ahn","sequence":"first","affiliation":[{"name":"College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University","place":["Seongnam, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Won","family":"Lee","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University","place":["Seongnam, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Young","family":"Lee","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University","place":["Seongnam, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon-Young","family":"Song","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University","place":["Seongnam, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Min","family":"Han","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University","place":["Seongnam, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong Yeob","family":"Jeon","sequence":"additional","affiliation":[{"name":"QBM Co., Ltd.","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Kyung","family":"Jang","sequence":"additional","affiliation":[{"name":"QBM Co., Ltd.","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Hee","family":"Kim","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University","place":["Seongnam, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: an expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"17019","DOI":"10.1038\/s41598-023-44198-0","article-title":"A model of hepatic steatosis with declined viability and function in a liver-organ-on-a-chip","volume":"13","author":"Wiriyakulsit","year":"2023","journal-title":"Sci Rep"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/ijmr.IJMR_1456_17","article-title":"Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: an increasing concern","volume":"149","author":"Dhamija","year":"2019","journal-title":"Indian J Med Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/s2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20205037","article-title":"Development and progression of non-alcoholic fatty liver disease: the role of advanced glycation end products","volume":"20","author":"Fernando","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"100524","DOI":"10.1016\/j.jhepr.2022.100524","article-title":"Understanding the cellular interactome of non-alcoholic fatty liver disease","volume":"4","author":"Wallace","year":"2022","journal-title":"J Hepatol Rep"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/s0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \"hits\"?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3746\/pnf.2019.24.2.103","article-title":"Health benefits of carotenoids: a role of carotenoids in the prevention of non-alcoholic fatty liver disease","volume":"24","author":"Lee","year":"2019","journal-title":"Prevent Nutr Food Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1291501","DOI":"10.3389\/fmed.2024.1291501","article-title":"Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies","volume":"11","author":"Habibullah","year":"2024","journal-title":"Front Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s44355-024-00004-w","article-title":"Resmetirom and GLP-1 agonists for MASH: complementary rather than exclusive","volume":"1","author":"Zhou","year":"2024","journal-title":"npj Gut Liver"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1172\/jci186420","article-title":"MASH: the nexus of metabolism, inflammation, and fibrosis","volume":"135","author":"Steinberg","year":"2025","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"970292","DOI":"10.3389\/fphys.2022.970292","article-title":"The AMPK pathway in fatty liver disease","volume":"13","author":"Fang","year":"2022","journal-title":"Front Physiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/labinvest.2010.75","article-title":"Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice","volume":"90","author":"Yamaguchi","year":"2010","journal-title":"Lab Investig"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e20190103","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J Exp Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1727043","DOI":"10.3389\/fnut.2025.1727043","article-title":"Processed silkworm powder (Hongjam) ameliorates metabolic dysfunction-associated steatotic liver disease via GPR35\/PKA and SIRT1\/AMPK pathways","volume":"12","author":"Lee","year":"2025","journal-title":"Front Nutr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/foods9030285","article-title":"Hepatoprotective effects of steamed and freeze-dried mature silkworm larval powder against ethanol-induced fatty liver disease in rats","volume":"9","author":"Lee","year":"2020","journal-title":"Foods"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030568","article-title":"Administration of steamed and freeze-dried mature silkworm larval powder prevents hepatic fibrosis and hepatocellular carcinogenesis by blocking TGF-\u03b2\/STAT3 signaling cascades in rats","volume":"9","author":"Lee","year":"2020","journal-title":"Cells"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1016\/j.cmet.2024.10.001","article-title":"Amino acid is a major carbon source for hepatic lipogenesis","volume":"36","author":"Liao","year":"2024","journal-title":"Cell Metab"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s10620-015-3977-1","article-title":"Animal models of nonalcoholic steatohepatitis: eat, delete, and inflame","volume":"61","author":"Ibrahim","year":"2016","journal-title":"Dig Dis Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.7852\/jses.2015.53.1.38","article-title":"Development of processing technology for edible mature silkworm","volume":"53","author":"Ji","year":"2015","journal-title":"J Seric Entomol Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"012","DOI":"10.7324\/JAPS.2017.70902","article-title":"Methionine and choline deficient diet-induced non-alcoholic steatohepatitis in rats: role of melatonin","volume":"7","author":"Amin","year":"2017","journal-title":"J Appl Pharm Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s44324-024-00022-5","article-title":"Autophagy and hepatic lipid metabolism: mechanistic insight and therapeutic potential for MASLD","volume":"2","author":"Raza","year":"2024","journal-title":"NPJ Metab Health Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1294267","DOI":"10.3389\/fmed.2023.1294267","article-title":"Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic","volume":"10","author":"Rao","year":"2023","journal-title":"Front Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","article-title":"The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance","volume":"40","author":"Rinella","year":"2004","journal-title":"J Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1369\/0022155415627681","article-title":"TGF-\u03b2\/SMAD pathway and its regulation in hepatic fibrosis","volume":"64","author":"Xu","year":"2016","journal-title":"J Histochem Cytochem"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jhep.2009.10.030","article-title":"NF-\u03baB signalling: embracing complexity to achieve translation","volume":"52","author":"Chakraborty","year":"2010","journal-title":"J Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.26599\/fmh.2024.9420020","article-title":"Inflammation and gut microbiota in the alcoholic liver disease","volume":"1","author":"Gao","year":"2024","journal-title":"Food Med Homol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"400","DOI":"10.21037\/atm.2020.02.184","article-title":"The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis","volume":"8","author":"M\u00e9ndez-S\u00e1nchez","year":"2020","journal-title":"Ann Transl Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1038\/s41467-023-41145-5","article-title":"MKP1 promotes nonalcoholic steatohepatitis by suppressing AMPK activity through LKB1 nuclear retention","volume":"14","author":"Qiu","year":"2023","journal-title":"Nat Commun"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"4777789","DOI":"10.1155\/2024\/4777789","article-title":"The AMPK-mTOR pathway is inhibited by Chaihu Shugan powder, which relieves nonalcoholic steatohepatitis by suppressing autophagic ferroptosis","volume":"2024","author":"Liang","year":"2024","journal-title":"Mediat Inflamm"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2025.106927","article-title":"Alleviating effects of koji-fermented soybean extract on nonalcoholic steatohepatitis in mice through inactivation of acetyl-CoA carboxylase without inhibition of AMPK","volume":"130","author":"Kitatani","year":"2025","journal-title":"J Funct Foods"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J Hepatol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"106372","DOI":"10.1016\/j.fitote.2024.106372","article-title":"Harnessing nature's arsenal: targeting the TGF-\u03b2\/Smad Cascade with novel natural anti-fibrotic agents","volume":"181","author":"Chen","year":"2025","journal-title":"Fitoterapia"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1839551\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:50:14Z","timestamp":1779771014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1839551\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":39,"alternative-id":["10.3389\/fnut.2026.1839551"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1839551","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"article-number":"1839551"}}